387 top medical experts on Gestational Trophoblastic Disease across 50 countries and 29 U.S. states, including 255 MDs (Physicians). This is based on an objective analysis of their Scientific Publications, Clinical Trials, Medicare, and NIH Grants.

  1. Gestational Trophoblastic Disease: A group of diseases arising from pregnancy that are commonly associated with hyperplasia of trophoblasts (trophoblast) and markedly elevated human chorionic gonadotropin. They include hydatidiform mole, invasive mole (hydatidiform mole, invasive), placental-site trophoblastic tumor (trophoblastic tumor, placental site), and choriocarcinoma. These neoplasms have varying propensities for invasion and spread.
  2. Clinical guidelines are the recommended starting point to understand initial steps and current protocols in any disease or procedure:
  3. Broader Categories (#Experts): Trophoblastic Neoplasms (436) and Narrower Categories: Hydatidiform Mole (2,111).
  4. Clinical Trials ClinicalTrials.gov : at least 27 including 1 Active, 9 Completed, 9 Recruiting
  5. Synonyms: Gestational Trophoblastic Neoplasms,  Gestational Trophoblastic Neoplasms


  

        

                    


    These expert listings are for individual use without a fee. Biotechs, Pharmaceuticals, Recruiters, Consultants, Investors, Law firms, and other organizations may use this only for quick evaluations (no downloads, screen scraping or using the data) to identify the top medical experts for recruiting, advisory panels, boards, and consulting. Please contact us for licensing, customized queries, feedback and questions.

  1. Berkowitz, Ross Stuart   Gynecologic Oncology   Google Publications
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Brigham and Womens Hospital, Boston, USA. Top Hospital
    Physician  Highly Cited  Highly Published  Case Reports 
    Medical school: Boston University School of Medicine (MD, 1973)
    Medicare Accepted
    Subjects: Uterine Neoplasms; Hydatidiform Mole; Antineoplastic Combined Chemotherapy Protocols; Antineoplastic Agents; Methotrexate
    Categories: Drug Therapy; Pathology; Therapy; Therapeutic Use; Epidemiology; Pharmacology
    Update on the diagnosis and management of gestational trophoblastic disease. (2018)
    Gestational trophoblastic disease. (2010)

  2. Horowitz, Neil Stuart   Obstetrics & Gynecology   Google Publications
    Brigham & Womens Hospital/Dana Farber Cancer Institute, Boston, MA, USA. Electronic address: .
    Physician  Highly Cited  Highly Published  Clinical Trial  Case Reports 
    Disclosed payments from biomedical company (Merck KGaA) in 2021 for $3,450
    Subjects: Uterine Neoplasms; Antineoplastic Combined Chemotherapy Protocols; Hydatidiform Mole; Antineoplastic Agents; Methotrexate
    Categories: Drug Therapy; Therapeutic Use; Administration & Dosage; Pathology; Therapy; Epidemiology
    Placental site trophoblastic tumors and epithelioid trophoblastic tumors: Biology, natural history, and treatment modalities. (2017)
    Gestational trophoblastic neoplasia lethality among Brazilian women: A retrospective national cohort study. (2020)

  3. Seckl, Michael J   Google Publications
    Trophoblastic Tumour Screening and Treatment Centre, Charing Cross Hospital, Imperial College Healthcare NHS Trust, London, UK. Electronic address: .
    Scientist  Highly Cited  Highly Published  Guideline  Case Reports  Review 
    Subjects: Uterine Neoplasms; Chorionic Gonadotropin; Antineoplastic Combined Chemotherapy Protocols; Methotrexate; Antimetabolites, Antineoplastic
    Categories: Drug Therapy; Therapeutic Use; Blood; Pathology; Therapy; Genetics
    Update on the diagnosis and management of gestational trophoblastic disease. (2018)
    Gestational trophoblastic disease. (2010)

  4. Elias, Kevin Meyer   Gynecologic Oncology   Google Publications
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Brigham and Womens Hospital, Boston, USA. Top Hospital
    Physician  Highly Cited  Highly Published 
    Disclosed payments in 2021 from 3 biomedical companies, totalling $3,595.49, including $3,450 from  Merck KGaA
    Subjects: Hydatidiform Mole; Uterine Neoplasms; Antineoplastic Combined Chemotherapy Protocols; Methotrexate; Antineoplastic Agents
    Categories: Drug Therapy; Pharmacology; Therapy; Epidemiology; Administration & Dosage; Biosynthesis
    Gestational trophoblastic neoplasia lethality among Brazilian women: A retrospective national cohort study. (2020)
    Predictors for single-agent resistance in FIGO score 5 or 6 gestational trophoblastic neoplasia: a multicentre, retrospective, cohort study. (2021)

  5. Schink, Julian C   Gynecologic Oncology   ClinicalTrials.gov Google Publications
    Cancer Treatment Centers of America, Comprehensive Care and Research Center, Chicago, IL, USA. Electronic address: .
    Physician  Highly Cited  Highly Published  Clinical Trial 
    Medical school: University of Texas Medical School at San Antonio (MD, 1982)
    Medicare Accepted
    Disclosed payments from biomedical company (AstraZeneca Pharmaceuticals LP) in 2021 for $124.96
    Subjects: Dactinomycin; Methotrexate; Antineoplastic Combined Chemotherapy Protocols; Uterine Neoplasms; Antimetabolites, Antineoplastic
    Categories: Drug Therapy; Therapeutic Use; Administration & Dosage; Pathology; Therapy; Mortality
    15years of progress in gestational trophoblastic disease: Scoring, standardization, and salvage. (2017)
    Phase III trial of weekly methotrexate or pulsed dactinomycin for low-risk gestational trophoblastic neoplasia: a gynecologic oncology group study. (2011)

  6. Goldstein, Donald Peter   Gynecologic Oncology   Google Publications
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Brigham and Womens Hospital, Boston, USA. Top Hospital
    Physician  Highly Cited  Highly Published  Case Reports 
    Subjects: Uterine Neoplasms; Hydatidiform Mole; Antineoplastic Combined Chemotherapy Protocols; Antineoplastic Agents; Methotrexate
    Categories: Drug Therapy; Therapeutic Use; Pathology; Therapy; Epidemiology; Ethnology
    Placental site trophoblastic tumors and epithelioid trophoblastic tumors: Biology, natural history, and treatment modalities. (2017)
    Effectiveness and toxicity of first-line methotrexate chemotherapy in low-risk postmolar gestational trophoblastic neoplasia: The New England Trophoblastic Disease Center experience. (2018)

  7. Lurain, John R   Gynecologic Oncology   Google Publications
    Robert H. Lurie Comprehensive Cancer Center of Northwestern University. Top Hospital
    Physician  Highly Cited  Highly Published  Case Reports 
    Subjects: Uterine Neoplasms; Antineoplastic Combined Chemotherapy Protocols; Choriocarcinoma; Chorionic Gonadotropin; Antimetabolites, Antineoplastic
    Categories: Pathology; Drug Therapy; Therapeutic Use; Therapy; Urine; Metabolism
    Update on the diagnosis and management of gestational trophoblastic disease. (2018)
    Gestational trophoblastic disease I: epidemiology, pathology, clinical presentation and diagnosis of gestational trophoblastic disease, and management of hydatidiform mole. (2010)

  8. Soper, John T   Gynecologic Oncology  Google Publications
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of North Carolina School of Medicine, Chapel Hill, North Carolina.
    Physician  Highly Cited  Highly Published 
    Medical school: University of Iowa, Rj & L Carver College of Medicine (MD, 1978)
    Medicare Accepted; Medicare MIPS (Merit-based Incentive Payment System) rating: 76/100
    Subjects: Brain Neoplasms; Lung Neoplasms; Trophoblastic Neoplasms; Uterine Neoplasms; Vaginal Neoplasms
    Categories: Surgery; Therapy; Drug Therapy; Pathology; Radiotherapy
    Gestational Trophoblastic Disease: Current Evaluation and Management. (2021)
    Trophoblastic disease. (2012)

  9. Brown, Jubilee   Gynecologic Oncology   Google Publications
    Division of Gynecologic Oncology, Levine Cancer Institute, Carolinas HealthCare System, Charlotte, NC.
    Physician 
    Medicare MIPS (Merit-based Incentive Payment System) rating: 78.2/100
    Disclosed payments in 2021 from 11 biomedical companies, totalling $7,853.32, including $2,800 from  Clovis Oncology, Inc.
    Subjects: Antineoplastic Combined Chemotherapy Protocols; Medical Futility; Population Surveillance; Salvage Therapy
    Categories: Therapeutic Use; Diagnosis; Drug Therapy; Methods; Surgery; Therapy
    15years of progress in gestational trophoblastic disease: Scoring, standardization, and salvage. (2017)
    Salvage chemotherapy for gestational trophoblastic neoplasia: Utility or futility? (2017)

  10. Kurman, Robert J   Anatomic Pathology & Clinical Pathology  Google Publications
    Departments of Pathology, Gynecology and Obstetrics and Oncology, The Johns Hopkins Medical Institution, Baltimore, Maryland.
    Physician 
    Disclosed payments in 2021 from 14 biomedical companies, totalling $17,034, including $17,034 from  Merck Sharp & Dohme Corporation
    Subjects: Placenta; Uterine Neoplasms; B7-H1 Antigen; Biomarkers, Tumor; Trophoblastic Neoplasms
    Categories: Pathology; Therapy; Analysis; Biosynthesis; Metabolism
    PD-L1 Expression in Human Placentas and Gestational Trophoblastic Diseases. (2017)
    Trophoblastic disease. (2012)

  11. Hui, Pei   Anatomic Pathology   Google Publications
    Department of Pathology, Yale University School of Medicine, New Haven, CT, USA. . Top Hospital
    Physician  Highly Published 
    Medicare MIPS (Merit-based Incentive Payment System) rating: 68/100
    Disclosed payments from biomedical company (Myovant Sciences Inc.) in 2021 for $1,500
    Subjects: Choriocarcinoma; Hydatidiform Mole; Immunohistochemistry; Molecular Diagnostic Techniques; Placenta
    Categories: Diagnosis; Genetics; Methods; Pathology; Trends
    Gestational Trophoblastic Tumors: A Timely Review of Diagnostic Pathology. (2019)
    Immunohistochemistry and other ancillary techniques in the diagnosis of gestational trophoblastic diseases. (2014)

  12. Ko, Emily M   Gynecologic Oncology  Google Publications
    Department of Obstetrics and Gynecology, University of Pennsylvania Health System, Philadelphia, PA. Top Hospital
    Physician  Review 
    Medicare MIPS (Merit-based Incentive Payment System) rating: 78/100
    Disclosed payments from biomedical company (Medical Device Business Services, Inc.) in 2021 for $13.35
    Subjects: Hydatidiform Mole; Uterine Neoplasms; Continuity of Patient Care; Vacuum Curettage
    Categories: Epidemiology; Surgery; Diagnosis; Economics
    Gestational Trophoblastic Neoplasia After Human Chorionic Gonadotropin Normalization Following Molar Pregnancy: A Systematic Review and Meta-analysis. (2020)
    Surveillance for gestational trophoblastic neoplasia following molar pregnancy: a cost-effectiveness analysis. (2021)

  13. Quade, Bradley J   Anatomic Pathology  Google Publications
    Division of Womens and Perinatal Pathology, Department of Pathology, Brigham and Womens Hospital, Harvard Medical School, Boston, MA, USA. Top Hospital
    Physician  Case Reports 
    Medical school: Washington University School of Medicine (MD, 1990)
    Medicare Accepted
    Subjects: Biomarkers, Tumor; GATA3 Transcription Factor; Placenta; Receptors, Estrogen; Trophoblastic Neoplasms
    Categories: Pathology; Biosynthesis; Metabolism; Analysis
    Epithelioid trophoblastic tumor: A single institution case series at the New England Trophoblastic Disease Center. (2015)
    GATA3 expression in gestational trophoblastic tissues and tumours. (2015)

  14. Growdon, Whitfield B   Gynecologic Oncology  Google Publications
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States of America. Top Hospital
    Physician  Highly Published 
    Subjects: Hydatidiform Mole; Uterine Neoplasms; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols
    Categories: Drug Therapy; Pathology; Therapeutic Use; Adverse Effects; Blood; Epidemiology
    Prognostic factors associated with time to hCG remission in patients with low-risk postmolar gestational trophoblastic neoplasia. (2013)
    Influence of hydatidiform mole follow-up setting on postmolar gestational trophoblastic neoplasia outcomes: a cohort study. (2012)

  15. Gockley, Allison Ann   Gynecologic Oncology  Google Publications
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Brigham and Womens Hospital, Boston, USA. Top Hospital
    Physician 
    Subjects: Uterine Neoplasms; Hydatidiform Mole; Racial Groups
    Categories: Ethnology; Epidemiology; Statistics & Numerical Data
    Clinical Presentation of Complete Hydatidiform Mole and Partial Hydatidiform Mole at a Regional Trophoblastic Disease Center in the United States Over the Past 2 Decades. (2016)
    Effect of race/ethnicity on clinical presentation and risk of gestational trophoblastic neoplasia in patients with complete and partial molar pregnancy at a tertiary care referral center. (2016)

  16. Melamed, Alexander   Gynecologic Oncology  Google Publications
    Department of Obstetrics, Gynecology & Reproductive Biology, Harvard Medical School Boston, MA, USA. Top Hospital
    Physician  Highly Published 
    Disclosed payments from biomedical company (Merck Sharp & Dohme Corporation) in 2021 for $15.23
    Subjects: Hydatidiform Mole; Uterine Neoplasms; Racial Groups
    Categories: Ethnology; Epidemiology; Diagnosis; Pathology; Statistics & Numerical Data
    Changing presentation of complete hydatidiform mole at the New England Trophoblastic Disease Center over the past three decades: does early diagnosis alter risk for gestational trophoblastic neoplasia? (2015)
    Clinical Presentation of Complete Hydatidiform Mole and Partial Hydatidiform Mole at a Regional Trophoblastic Disease Center in the United States Over the Past 2 Decades. (2016)

  17. Aghajanian, Carol   Medical Oncology  Google Publications
    3 Gynecologic Medical Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center , New York, New York. Top Hospital
    Physician  Clinical Trial 
    Disclosed payments in 2021 from 8 biomedical companies, totalling $1,674.35, including $1,518.4 from  F. Hoffmann-La Roche AG
    Subjects: Antineoplastic Agents; Biomarkers, Tumor; Chorionic Gonadotropin; Dactinomycin; Emotions
    Categories: Administration & Dosage; Blood; Etiology; Adverse Effects; Drug Therapy; Pathology
    Treatment of low-risk gestational trophoblastic neoplasia. (2011)
    Association of ß-hCG Surveillance with Emotional, Reproductive, and Sexual Health in Women Treated for Gestational Trophoblastic Neoplasia. (2018)

  18. Havrilesky, Laura J   Gynecologic Oncology  Google Publications
    Department of Obstetrics and Gynecology, Duke University Medical Center, Durham, NC. Top Hospital
    Physician 
    Medical school: Duke University School of Medicine (MD, 1995)
    Medicare Accepted
    Subjects: Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Continuity of Patient Care; Dactinomycin; Hydatidiform Mole
    Categories: Economics; Epidemiology; Diagnosis; Drug Therapy
    Are different methotrexate regimens as first line therapy for low risk gestational trophoblastic neoplasia more cost effective than the dactinomycin regimen used in GOG 0174? (2017)
    Surveillance for gestational trophoblastic neoplasia following molar pregnancy: a cost-effectiveness analysis. (2021)

  19. Neubauer, Nikki L   Gynecologic Oncology  Google Publications
    John I. Brewer Trophoblastic Disease Center, Northwestern University Feinberg School of Medicine, Chicago, IL, USA. Top Hospital
    Physician 
    Disclosed payments in 2021 from 2 biomedical companies, totalling $42, including $22.35 from  Eisai Inc.
    Subjects: Brain Neoplasms
    Categories: Mortality; Therapy
    Brain metastasis in gestational trophoblastic neoplasia: an update. (2012)
    Fatal gestational trophoblastic neoplasia: An analysis of treatment failures at the Brewer Trophoblastic Disease Center from 1979-2012 compared to 1962-1978. (2015)

  20. Schott, Anne Marie   Medical Oncology   Google Publications
    Pôle Information Médicale Evaluation Recherche, Equipe dAccueil 4129, Hospices Civils de Lyon, Lyon.
    Physician  Highly Cited  Highly Published  Guideline 
    Disclosed payments from biomedical company (Gilead Sciences, Inc.) in 2021 for $11.92
    Subjects: Hydatidiform Mole; Antimetabolites, Antineoplastic; Brain Neoplasms; Chorionic Gonadotropin; Uterine Neoplasms
    Categories: Diagnosis; Therapeutic Use; Drug Therapy; Pathology; Blood; Immunology
    Mortality rate of gestational trophoblastic neoplasia with a FIGO score of ≥13. (2016)
    Formalised consensus of the European Organisation for Treatment of Trophoblastic Diseases on management of gestational trophoblastic diseases. (2015)

Note:
  1. These experts have limited publications on this topic in our database, so expertise assessment may not be accurate.
  2. Only the top 20 experts are shown. You may filter your results or use the geolocation tabs. Contact us to purchase the entire list.
These expert listings are for individual use without a fee. Biotechs, Pharmaceuticals, Recruiters, Consultants, Investors, Law firms, and other organizations may use this only for quick evaluations (no downloads or screen scraping) to identify the top medical experts for recruiting, advisory panels, boards, and consulting. Please contact us for licensing, customized queries, feedback and questions.

);